Hawkins, Inc. Form 10-Q

Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549


FORM 10-Q


QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2007

Commission file number 0-7647



 

HAWKINS, INC.

(Exact name of registrant as specified in its charter)


 

 

MINNESOTA

41-0771293

(State or other jurisdiction of
incorporation or organization)

(I.R.S. Employer Identification No.)


 

3100 EAST HENNEPIN AVENUE, MINNEAPOLIS, MINNESOTA 55413

(Address of principal executive offices, including zip code)

 

(612) 331-6910

(Registrant’s telephone number, including area code)



Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.

YES   x    NO   o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer (as defined in Rule 12b-2 of the Exchange Act).

Large Accelerated Filer o  Accelerated Filer x  Non-Accelerated Filer o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

YES   o    NO   x

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

 

 

CLASS

OUTSTANDING AT NOVEMBER 9, 2007

 

Common Stock, par value $.05 per share

10,264,084






HAWKINS, INC.
INDEX TO FORM 10-Q

 

 

 

 

 

 

Page

 

 

 

 

PART I.

FINANCIAL INFORMATION

 

 

 

 

 

 

Item 1.

Financial Statements:

 

 

 

 

 

 

 

Condensed Balance Sheets – September 30, 2007 and April 1, 2007

3

 

 

 

 

 

 

Condensed Statements of Income - Three and Six Months Ended September 30, 2007 and 2006

4

 

 

 

 

 

 

Condensed Statements of Cash Flows - Six Months Ended September 30, 2007 and 2006

5

 

 

 

 

 

 

Notes to Condensed Financial Statements – Unaudited

6

 

 

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

9

 

 

 

 

 

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

13

 

 

 

 

 

Item 4.

Controls and Procedures

14

 

 

 

 

 

PART II.

OTHER INFORMATION

 

 

 

 

 

 

Item 1A.

Risk Factors

15

 

 

 

 

 

Item 4.

Submission of Matters to a Vote of Security Holders

15

 

 

 

 

 

Item 6.

Exhibits

15

 

 

 

 

 

Signatures

16

 

 

 

 

 

Exhibit Index

17

 

2


Table of Contents

PART I. FINANCIAL INFORMATION

 

 

ITEM 1.

FINANCIAL STATEMENTS

HAWKINS, INC.
CONDENSED BALANCE SHEETS

 

 

 

 

 

 

 

 

 

 

SEPTEMBER 30,
2007
(UNAUDITED)

 

APRIL 1,
2007
(DERIVED FROM AUDITED
FINANCIAL STATEMENTS
)

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CURRENT ASSETS:

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

13,691,042

 

$

11,592,939

 

Investments available-for-sale

 

 

10,457,960

 

 

13,712,540

 

Trade receivables - net

 

 

19,322,925

 

 

19,663,169

 

Inventories

 

 

19,268,112

 

 

12,786,348

 

Prepaid expenses and other current assets

 

 

1,355,363

 

 

3,214,254

 

 

 

   

 

   

 

Total current assets

 

 

64,095,402

 

 

60,969,250

 

 

 

 

 

 

 

 

 

PROPERTY, PLANT AND EQUIPMENT – net

 

 

35,636,820

 

 

34,720,460

 

 

 

 

 

 

 

 

 

INTANGIBLE ASSETS - less accumulated amortization of $1,822,784 and $1,643,308, respectively

 

 

7,140,016

 

 

1,839,725

 

 

 

 

 

 

 

 

 

LONG-TERM INVESTMENTS

 

 

1,555,310

 

 

3,013,888

 

 

 

 

 

 

 

 

 

OTHER ASSETS

 

 

576,477

 

 

725,271

 

 

 

   

 

   

 

 

 

$

109,004,025

 

$

101,268,594

 

 

 

   

 

   

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CURRENT LIABILITIES:

 

 

 

 

 

 

 

Accounts payable – trade

 

$

14,597,261

 

$

10,891,162

 

Dividends payable

 

 

2,463,380

 

 

2,247,686

 

Accrued payroll and employee benefits

 

 

4,294,530

 

 

5,221,005

 

Other current liabilities

 

 

2,739,225

 

 

2,371,904

 

 

 

   

 

   

 

Total current liabilities

 

 

24,094,396

 

 

20,731,757

 

 

 

 

 

 

 

 

 

OTHER LONG-TERM LIABILITIES

 

 

132,023

 

 

138,673

 

 

 

 

 

 

 

 

 

DEFERRED INCOME TAXES

 

 

443,767

 

 

420,521

 

 

 

 

 

 

 

 

 

COMMITMENTS AND CONTINGENCIES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SHAREHOLDERS’ EQUITY:

 

 

 

 

 

 

 

Common stock, par value $.05 per share; 10,211,827 and 10,171,496 shares issued and outstanding, respectively

 

 

510,591

 

 

508,575

 

Additional paid-in capital

 

 

38,150,662

 

 

37,242,090

 

Accumulated other comprehensive gain (loss)

 

 

22,894

 

 

(13,605

)

Retained earnings

 

 

45,649,692

 

 

42,240,583

 

 

 

   

 

   

 

Total shareholders’ equity

 

 

84,333,839

 

 

79,977,643

 

 

 

   

 

   

 

 

 

$

109,004,025

 

$

101,268,594

 

 

 

   

 

   

 

See accompanying notes to condensed financial statements – unaudited.

3


Table of Contents

HAWKINS, INC.
CONDENSED STATEMENTS OF INCOME

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

THREE MONTHS ENDED
SEPTEMBER 30

 

SIX MONTHS ENDED
SEPTEMBER 30

 

 

 

 

 

 

 

 

 

2007

 

2006

 

2007

 

2006

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(UNAUDITED)

 

(UNAUDITED)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales

 

$

48,143,856

 

$

42,200,162

 

$

96,766,581

 

$

83,660,825

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of sales

 

 

36,268,357

 

 

31,023,515

 

 

73,060,531

 

 

61,661,093

 

 

 

   

 

   

 

   

 

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross margin

 

 

11,875,499

 

 

11,176,647

 

 

23,706,050

 

 

21,999,732

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

 

7,498,645

 

 

6,482,276

 

 

14,993,929

 

 

13,119,141

 

 

 

   

 

   

 

   

 

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income from operations

 

 

4,376,854

 

 

4,694,371

 

 

8,712,121

 

 

8,880,591

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investment income

 

 

312,265

 

 

347,757

 

 

614,568

 

 

649,004

 

 

 

   

 

   

 

   

 

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income before income taxes

 

 

4,689,119

 

 

5,042,128

 

 

9,326,689

 

 

9,529,595

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Provision for income taxes

 

 

1,767,700

 

 

1,896,000

 

 

3,454,200

 

 

3,583,500

 

 

 

   

 

   

 

   

 

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

2,921,419

 

$

3,146,128

 

$

5,872,489

 

$

5,946,095

 

 

 

   

 

   

 

   

 

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of shares
outstanding – basic

 

 

10,211,827

 

 

10,171,496

 

 

10,198,531

 

 

10,171,496

 

 

 

   

 

   

 

   

 

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of shares
outstanding – diluted

 

 

10,241,865

 

 

10,171,496

 

 

10,223,228

 

 

10,171,496

 

 

 

   

 

   

 

   

 

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per share – basic

 

$

0.29

 

$

0.31

 

$

0.58

 

$

0.58

 

 

 

   

 

   

 

   

 

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per share – diluted

 

$

0.29

 

$

0.31

 

$

0.57

 

$

0.58

 

 

 

   

 

   

 

   

 

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash dividends declared per common share

 

$

0.24

 

$

0.22

 

$

0.24

 

$

0.22

 

 

 

   

 

   

 

   

 

   

 

See accompanying notes to condensed financial statements - unaudited.

4


Table of Contents

HAWKINS, INC.
CONDENSED STATEMENTS OF CASH FLOWS

 

 

SIX MONTHS ENDED
SEPTEMBER 30

 

 

 

2007

 

2006

 

 

 

(UNAUDITED)

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

 

 

 

 

Net income

 

$

5,872,489

 

$

5,946,095

 

Reconciliation to cash flows:

 

 

 

 

 

 

 

Depreciation and amortization

 

 

2,497,776

 

 

1,878,365

 

Restricted stock compensation expense

 

 

322,588

 

 

 

Impairment of investments

 

 

 

 

30,595

 

Loss from property disposals

 

 

59,632

 

 

66,446

 

Changes in operating accounts providing (using) cash:

 

 

 

 

 

 

 

Trade receivables

 

 

1,454,984

 

 

(517,716

)

Inventories

 

 

(6,216,449

)

 

(4,212,962

)

Accounts payable

 

 

2,659,498

 

 

(1,758,173

)

Other liabilities

 

 

(1,240,409

)

 

281,746

 

Other

 

 

2,013,176

 

 

493,761

 

 

 

   

 

   

 

 

 

 

 

 

 

 

 

Net cash provided by operating activities

 

 

7,423,285

 

 

2,208,157

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

 

 

 

 

Additions to property, plant and equipment

 

 

(2,626,476

)

 

(2,859,147

)

Sale and maturities of investments

 

 

4,751,977

 

 

1,588,710

 

Proceeds from property disposals

 

 

59,604

 

 

74,494

 

Payments received on notes receivable

 

 

 

 

83,396

 

Acquisition of Trumark

 

 

(5,262,601

)

 

 

 

 

   

 

   

 

 

 

 

 

 

 

 

 

Net cash used in investing activities

 

 

(3,077,496

)

 

(1,112,547

)

 

 

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

 

 

 

 

Cash dividends paid

 

 

(2,247,686

)

 

(2,034,299

)

 

 

   

 

   

 

 

 

 

 

 

 

 

 

Net cash used in financing activities

 

 

(2,247,686

)

 

(2,034,299

)

 

 

   

 

   

 

 

 

 

 

 

 

 

 

INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

 

 

2,098,103

 

 

(938,689

)

 

 

 

 

 

 

 

 

CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD

 

 

11,592,939

 

 

6,330,004

 

 

 

   

 

   

 

 

 

 

 

 

 

 

 

CASH AND CASH EQUIVALENTS, END OF PERIOD

 

$

13,691,042

 

$

5,391,315

 

 

 

   

 

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash paid for income taxes

 

$

1,473,790

 

$

2,823,000

 

 

 

 

 

 

 

 

 

Noncash investing activities-
Capital expenditures in accounts payable

 

$

617,352

 

$

267,042

 

See accompanying notes to condensed financial statements - unaudited.

5


Table of Contents

HAWKINS, INC.
NOTES TO CONDENSED FINANCIAL STATEMENTS - UNAUDITED

 

 

1.

The accompanying unaudited condensed financial statements have been prepared in accordance with the instructions for Form 10-Q and, accordingly, do not include all information and footnotes required by generally accepted accounting principles for complete financial statements. These statements should be read in conjunction with the financial statements and footnotes included in the Company’s Annual Report on Form 10-K for the fiscal year ended April 1, 2007, previously filed with the Securities and Exchange Commission (the “Commission”). In the opinion of management, the accompanying unaudited condensed financial statements contain all adjustments necessary to present fairly the Company’s financial position and the results of its operations and cash flows for the periods presented. All adjustments made to the interim financial statements were of a normal recurring nature.

 

 

 

The accounting policies followed by the Company are set forth in Note 1 to the Company’s financial statements in the Company’s Annual Report on Form 10-K for the fiscal year ended April 1, 2007 filed with the Commission on June 15, 2007.

 

 

 

In the preparation of the Company’s financial statements, management calculates income taxes based upon the estimated effective rate applicable to operating results for the full fiscal year. This includes estimating the current tax liability as well as assessing differences resulting from different treatment of items for tax and book accounting purposes. These differences result in deferred tax assets and liabilities, which are recorded on the balance sheet. These assets and liabilities are analyzed regularly and management assesses the likelihood that deferred tax assets will be recovered from future taxable income. The Company records any interest and penalties related to income taxes as income tax expense in the condensed statements of income.

 

 

 

The Company is subject to U.S. federal income tax as well as income tax of multiple state jurisdictions. The tax years beginning with 2003 remain open to examination by the Internal Revenue Service. The sufficient state jurisdictions of Minnesota, Iowa, North Dakota, South Dakota, and Wisconsin have tax years beginning with 2003 open to examination.

 

 

2.

The results of operations for the periods ended September 30, 2007 are not necessarily indicative of the results that may be expected for the full year.

 

 

3.

Inventories, principally valued by the LIFO method, are less than current cost by approximately $3,110,000 and $3,170,000 at September 30, 2007 and April 1, 2007, respectively. Inventory consists principally of finished goods.

 

 

4.

A summary of our intangible assets and goodwill is as follows:


 

 

 

 

 

 

 

 

 

Amortizable
Intangible Assets
April 1, 2007

 

 

 

 

 

 

 

 

Gross

 

$

3,483,033

 

 

Accumulated amortization

 

 

(1,643,308

)

 

 

 

   

 

 

Net

 

$

1,839,725

 

 

 

 

   

 


 

 

 

 

 

 

 

 

 

 

 

 

Unamortizable
Intangible Assets

 

Amortizable
Intangible Assets

 

 

 

 

September 30, 2007

 

 

 

 

 

 

 

 

Gross

 

$

1,228,000

 

$

6,214,032

 

 

Accumulated amortization

 

 

 

 

(1,822,784

)

 

 

 

         

 

 

Net

 

$

1,228,000

 

$

4,391,248

 

 

 

 

         

 


 

 

 

Intangible assets consist primarily of customer lists, trademarks, and trade names in current and previous business acquisitions.

6


Table of Contents

 

 

 

The change in the carrying amount of goodwill (included in Intangible Assets on the statement of financial condition) for the six months ended September 30, 2007 is as follows:


 

 

 

 

 

 

 

Balance April 1, 2007

 

$

 

 

Goodwill associated with acquisition

 

 

1,520,768

 

 

 

 

   

 

 

Balance September 30, 2007

 

$

1,520,768

 

 

 

 

   

 


 

 

5.

Comprehensive income and its components, net of tax, were as follows:


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended
September 30

 

Six months ended
September 30

 

 

 

 

 

 

 

 

 

2007

 

2006

 

2007

 

2006

 

 

Net income

 

$

2,921,419

 

$

3,146,128

 

$

5,872,489

 

$

5,946,095

 

Available-for-sale investments unrealized gain

 

 

57,080

 

 

80,449

 

 

36,499

 

 

79,637

 

 

 

   

 

   

 

   

 

   

 

Comprehensive income

 

$

2,978,499

 

$

3,226,577

 

$

5,908,988

 

$

6,025,732

 

 

 

   

 

   

 

   

 

   

 


 

 

6.

We adopted Financial Accounting Standards Board (FASB) Interpretation (FIN) No. 48, “Accounting for Uncertainty in Income Taxes - an interpretation of FASB Statement No. 109” on April 2, 2007. The adoption of FIN 48 resulted in no impact on our results of operations and financial condition.

In September 2006, the FASB issued Statement of Financial Accounting Standards (SFAS) No. 157, “Fair Value Measurements.” This statement establishes a consistent framework for measuring fair value and expands disclosures on fair value measurements. SFAS 157 is effective for the Company starting in fiscal 2009. We have not determined the impact, if any, the adoption of this statement will have on our financial statements.

 

 

 

In February 2007, the FASB issued SFAS No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities.” SFAS 159 permits entities to choose to measure many financial instruments and certain other items at fair value that are not currently required to be measured at fair value. SFAS 159 is effective for fiscal years beginning after November 15, 2007. We are currently evaluating the impact of adopting SFAS 159 on our results of operations and financial condition.

 

 

 

In June 2007, the FASB ratified the Emerging Issues Task Force (EITF) Issue No. 06-11, “Accounting for Income Tax Benefits of Dividends on Share Based Payment Awards.” EITF 06-11 requires companies to recognize the income tax benefit realized from dividends or dividend equivalents that are charged to retained earnings and paid to employees for nonvested equity-classified employee share-based awards as an increase to additional paid-in capital. EITF 06-11 is effective for fiscal years beginning after September 15, 2007. We are currently evaluating the impact of adopting EITF 06-11 on our results of operations and financial condition.

 

 

 

In June 2007, the FASB ratified EITF Issue No. 07-03, “Accounting for Nonrefundable Advance Payments for Goods and Services Received for Use in Future Research and Development Activities.” EITF 07-03 requires companies to defer nonrefundable advance payments for goods and services and to expense that advance payment as the goods are delivered or services are rendered. If the company does not expect to have the goods delivered or services performed, the advance should be expensed. EITF 07-03 is effective for fiscal years beginning after December 15, 2007. We are currently evaluating the impact of adopting EITF 07-03 on our results of operations and financial condition.

 

 

7.

The Company is involved in various legal actions arising from the normal course of business from time to time. Management is of the opinion that any judgment or settlement resulting from pending or threatened litigation would not have a material adverse effect on the financial position, results of operations or cash flows of the Company.

 

 

 

The Company has two leases of land, and at the end of the lease term (currently 2018 if the leases are not renewed), the Company has a specified amount of time to remove the property and buildings. At the end of the specified amount of time, anything that remains on the land becomes the property of the lessor, and the lessor has the option to either maintain the property or remove the property at the Company’s expense. The Company has not been able to reasonably estimate the fair value of the asset retirement obligations, primarily due to the combination of the following factors: the leases do not expire in the near future; the Company has a history of extending the leases with the lessor and currently intends to do so at expiration of this lease period; the lessor does not have a history of terminating leases with its tenants; and because it is more likely than not that the buildings will have value at the end of the lease life and therefore, may not be removed by either the lessee or the lessor. Therefore, in accordance with SFAS No. 143, “Accounting for Asset Retirement Obligations,” and FIN 47, “Accounting for Conditional Asset Retirement Obligations- an interpretation of FASB Statement No. 143,” the Company has not recorded an asset retirement obligation as of September 30, 2007. The Company will continue to monitor the factors surrounding the requirement to record an asset retirement obligation and will recognize the fair value of a liability in the period in which it is incurred and a reasonable estimate can be made.

7


Table of Contents

 

 

8.

On December 15, 2006, the Company issued 45,257 shares of restricted stock to certain employees of the Company. The restricted stock awards are recorded as compensation cost over the requisite vesting period, which is one year of service, based on the market value on the date of grant. The grant date fair value on December 15, 2006 was $14.09. As of September 30, 2007, there was approximately $133,000 of total unrecognized compensation cost related to nonvested share-based compensation for this award.

 

 

 

On September 18, 2007, the Company issued 7,000 shares of restricted stock to the Board of Directors as part of their annual retainer for their Board services. The restricted stock awards are expensed over the requisite vesting period, which is one year of service, based on the market value on the date of grant. The grant date fair value on September 18, 2007 was $14.48. As of September 30, 2007, there was approximately $98,000 of total unrecognized compensation cost related to nonvested share-based compensation for this award.

 

 

9.

On May 15, 2007, the Company signed an asset purchase agreement with Trumark, Inc., Trumark Ltd., Profloc Inc. (collectively Trumark) and the shareholders of each entity, under which the Company agreed to acquire substantially all of the assets of the entities and assume certain operating liabilities for approximately $6,000,000 in cash and stock consideration. On May 31, 2007, the acquisition was completed. The acquired business is a producer of antimicrobial products for the food industry. The acquired business is included in the Company’s Industrial operating segment.

 

 

 

The assets acquired consist of assets used by Trumark to operate its business, including intellectual property, manufacturing equipment and inventory. The purchase price consisted of cash and shares of the Company’s stock. The Company funded the cash portion of the transaction with existing cash and issued new shares of common stock. The Company is continuing to identify and quantify assets acquired and liabilities assumed to complete the allocation of the purchase price.

 

 

 

The operations of Trumark are included in the Company’s statement of income beginning on June 1, 2007. The proforma effect of this acquisition on prior period sales, operating income, and earnings per share was not significant.





8


Table of Contents

 

 

10.

The Company has three reportable segments: Industrial, Water Treatment and Pharmaceutical. Reportable segments are defined by product and type of customer. Segments are responsible for the sales, marketing and development of their products and services. The accounting policies of the segments are the same as those described in the summary of significant accounting policies. Product costs and expenses for each segment are based on actual costs incurred along with cost allocation of shared and centralized functions. The Company evaluates performance based on profit or loss from operations before income taxes not including nonrecurring gains and losses. The segments do not have separate accounting, administration, customer service or purchasing functions. There are no intersegment sales and no operating segments have been aggregated. Sales are primarily within the United States and all assets are located within the United States.


 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reportable Segments

 

Industrial

 

Water Treatment

 

Pharmaceutical

 

Total

 

 

 

 

 

Three Months Ended September 30, 2007:

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales

 

$

28,435,618

 

$

17,446,735

 

$

2,261,503

 

$

48,143,856

 

Gross margin

 

 

5,007,679

 

 

6,088,817

 

 

779,003

 

 

11,875,499

 

Income from operations

 

$

621,605

 

$

3,647,828

 

$

107,421

 

$

4,376,854

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30, 2006:

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales

 

$

23,027,848

 

$

16,718,530

 

$

2,453,784

 

$

42,200,162

 

Gross margin

 

 

4,981,466

 

 

5,417,211

 

 

777,970

 

 

11,176,647

 

Income from operations

 

$

1,193,901

 

$

3,376,603

 

$

123,867

 

$

4,694,371

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended September 30, 2007:

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales

 

$

57,720,243

 

$

34,369,784

 

$

4,676,554

 

$

96,766,581

 

Gross margin

 

 

10,507,532

 

 

11,641,779

 

 

1,556,739

 

 

23,706,050

 

Income from operations

 

$

1,585,144

 

$

6,860,940

 

$

266,037

 

$

8,712,121

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended September 30, 2006:

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales

 

$

46,427,190

 

$

32,387,247

 

$

4,846,388

 

$

83,660,825

 

Gross margin

 

 

10,084,770

 

 

10,415,231

 

 

1,499,731

 

 

21,999,732

 

Income from operations

 

$

2,482,655

 

$

6,248,803

 

$

149,133

 

$

8,880,591

 


 

 

ITEM 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

FORWARD-LOOKING INFORMATION

The information contained in this Quarterly Report on Form 10-Q for the period ended September 30, 2007 contains statements that we believe to be “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements give our current expectations or forecasts of future events. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “project,” or “continue,” or the negative thereof or similar words. From time to time, we also may provide oral or written forward-looking statements in other materials we release to the public. Any or all of our forward-looking statements in this Quarterly Report on Form 10-Q and in any public statements we make could be materially different from actual results. They can be affected by assumptions we might make or by known or unknown risks or uncertainties, including those described in Item 1A “Risk Factors” and other factors disclosed throughout this Quarterly Report on Form 10-Q and the Company’s other filings with the Securities and Exchange Commission. Consequently, we cannot guarantee any forward-looking statements and undertake no obligation to revise any forward-looking statements in order to reflect events or circumstances that may arise after the date of this Quarterly Report on Form 10-Q. Investors are cautioned not to place undue reliance on any forward-looking statements. Investors should also understand that it is not possible to predict or identify all factors that might affect actual results and should not consider these factors to be a complete statement of all potential risks and uncertainties. We assume no obligation and disclaim any duty to update the forward-looking statements in this Quarterly Report on Form 10-Q or any other public statement.

9


Table of Contents

RESULTS OF OPERATIONS

The following table sets forth the percentage relationship of certain items to sales for the period indicated (in thousands, except percentages):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

THREE MONTHS ENDED
SEPTEMBER 30, 2007

 

SIX MONTHS ENDED
SEPTEMBER 30, 2007

 

 

 

 

 

 

 

 

 

 

 

 

Sales

 

$

48,144

 

 

100.0

%

$

96,767

 

 

100.0

%

Cost of sales

 

 

36,268

 

 

75.3

 

 

73,061

 

 

75.5

 

 

 

   

 

   

 

   

 

   

 

Gross margin

 

 

11,875

 

 

24.7

 

 

23,706

 

 

24.5

 

Selling, general and administrative expenses

 

 

7,499

 

 

15.6

 

 

14,993

 

 

15.5

 

 

 

   

 

   

 

   

 

   

 

Income from operations

 

 

4,377

 

 

9.1

 

 

8,712

 

 

9.0

 

Investment income

 

 

312

 

 

0.6

 

 

615

 

 

0.6

 

 

 

   

 

   

 

   

 

   

 

Income before income taxes

 

 

4,689

 

 

9.7

 

 

9,327

 

 

9.6

 

Provision for income taxes

 

 

1,768

 

 

3.7

 

 

3,454

 

 

3.6

 

 

 

   

 

   

 

   

 

   

 

Net income

 

$

2,921

 

 

6.1

%

$

5,872

 

 

6.1

%

 

 

   

 

   

 

   

 

   

 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

THREE MONTHS ENDED
SEPTEMBER 30, 2006

 

SIX MONTHS ENDED
SEPTEMBER 30, 2006

 

 

 

 

 

 

 

 

 

 

 

 

Sales

 

$

42,200

 

 

100.0

%

$

83,661

 

 

100.0

%

Cost of sales

 

 

31,024

 

 

73.5

 

 

61,661

 

 

73.7

 

 

 

   

 

   

 

   

 

   

 

Gross margin

 

 

11,177

 

 

26.5

 

 

22,000

 

 

26.3

 

Selling, general and administrative expenses

 

 

6,482

 

 

15.4

 

 

13,119

 

 

15.7

 

 

 

   

 

   

 

   

 

   

 

Income from operations

 

 

4,694

 

 

11.1

 

 

8,881

 

 

10.6

 

Investment income

 

 

348

 

 

0.8

 

 

649

 

 

0.8

 

 

 

   

 

   

 

   

 

   

 

Income before income taxes

 

 

5,042

 

 

11.9

 

 

9,530

 

 

11.4

 

Provision for income taxes

 

 

1,896

 

 

4.5

 

 

3,584

 

 

4.3

 

 

 

   

 

   

 

   

 

   

 

Net income

 

$

3,146

 

 

7.5

%

$

5,946

 

 

7.1

%

 

 

   

 

   

 

   

 

   

 

Sales increased $5,943,694, or 14.1%, in the three months ended September 30, 2007, and increased $13,105,756, or 15.7%, in the six months ended September 30, 2007 as compared to the same periods a year ago. Sales of bulk chemicals, including caustic soda, were approximately 35% and 33% of sales for the three and six months ended September 30, 2007, respectively, compared to approximately 36% and 35% in the comparable periods a year ago. Industrial segment sales increased by $5,407,770 in the three months ended September 30, 2007 and increased by $11,293,053 in the six-month period ended September 30, 2007 as compared to the comparable periods in fiscal 2007. The Industrial segment’s sales increase was related to the Trumark acquisition, which was completed on May 31, 2007, increased sales within existing product lines primarily related to higher volume, lower margin products and price increases commensurate with rising material costs. Caustic soda volumes sold increased slightly as compared to the prior year periods. Water Treatment segment sales increased by $728,205 in the three months ended September 30, 2007 and increased $1,982,537 in the six-month period ended September 30, 2007, as compared to the same periods in fiscal 2007. These increases resulted from volume increases related to favorable weather conditions during the first quarter of fiscal 2008 and successful expansion of existing product lines to new and existing customers. Pharmaceutical sales decreased by 7.8% to $2,261,503 for the three months ended September 30, 2007 and decreased by 3.5% to $4,676,554 for the six months ended September 30, 2007 as compared to the same periods in fiscal 2007. The Pharmaceutical segment was still under restrictions for the ability to sell certain products by the Minneapolis District Office of the Food and Drug Administration (the “FDA”) as of September 30, 2007. The FDA matter is described in more detail below.

In September 2006, the Company received a warning letter from the FDA. The Company responded to this letter and subsequently received a letter from the FDA in November 2006 requesting that the Company cease shipments of certain products until it resolved certain issues with the FDA with respect to the validation of packaging configurations and expiration dating for those products. The Company has been working to resolve this matter as promptly as possible and subsequent to September 30, 2007, received clearance from the FDA to sell the majority of the products initially affected. The Company currently has approximately $8,000 of Pharmaceutical products in inventory that it is not permitted to sell as a result of this matter. Although sales within the Pharmaceutical segment were negatively impacted in the second half of fiscal 2007 and the first half of fiscal 2008, the Company has not had a material impact to its results of operations or cash flows.

10


Table of Contents

Gross margin, as a percentage of sales, for the three and six months ended September 30, 2007 was 24.7% and 24.5%, respectively, compared to 26.5% and 26.3%, respectively, for the comparable periods of fiscal 2007. For the Industrial segment, gross margin, as a percentage of sales, was 17.6% and 21.6% for the three months ended September 30, 2007 and September 30, 2006, respectively, and 18.2% for the six months ended September 30, 2007 compared to 21.7% for the comparable period in fiscal 2007. The decreases are primarily due to a majority of the sales increases relating to higher volume, lower margin products. Additionally, due to the LIFO method of valuing inventory, the prior year margin was positively impacted by changes in the cost of caustic soda and changes in inventory levels. The Company attempts to maintain relatively constant dollar margins as product costs increase or decrease. By attempting to maintain relatively stable dollar margins, the gross margin percentage will decrease when the product costs are increasing and will increase when product costs are decreasing. Many of the Company’s products are commodity based and therefore are subject to fluctuations, which is expected to continue in future periods. Gross margin, as a percentage of sales, for the Water Treatment segment was 34.9% for the three months ended September 30, 2007 compared to 32.4% in the comparable period of fiscal 2007 and 33.9% for the six-month period ended September 30, 2007 compared to 32.2% for the comparable period of fiscal 2007. The improvement during the six months ended September 30, 2007 was primarily attributable to an increase in sales volumes and to a lesser extent, changes in product mix. Gross margin, as a percentage of sales, for the Pharmaceutical segment was 34.4% for the three months ended September 30, 2007 compared to 31.7% in the comparable period of fiscal 2007 and was 33.3% for the six months ended September 30, 2007 compared to 30.9% for the same period a year ago. The increases are primarily related to a decrease in operating expenses due to a decrease in personnel.

Selling, general and administrative expenses, as a percentage of sales, for the three and six months ended September 30, 2007 were 15.6% ($7,498,645) and 15.5% ($14,993,929), respectively, compared to 15.4% ($6,482,276) and 15.7% ($13,119,141) for the comparable periods a year ago. A significant portion of the $1,874,788 increase for the six months ended September 30, 2007 was due to system enhancements and costs associated with the Company’s implementation of an Enterprise Resource Planning (ERP) system, including consultants and contractors, additional employees and depreciation expense. Consulting and contractor fees were approximately $463,000 and $1,000,000 during the three and six months ended September 30, 2007, respectively, which are expected to continue during fiscal 2008 and gradually decrease in fiscal 2009. Additionally, the acquisition of Trumark added additional fixed costs, and approximately $300,000 of non-recurring expenses were incurred during the six months ended September 30, 2007.

INVESTMENT INCOME

Investment income of $614,568 for the six months ended September 30, 2007 was comparable to $649,004 earned during the same period a year ago.

PROVISION FOR INCOME TAXES

The effective income tax rate was 37.7% and 37.0% for the three and six months ended September 30, 2007, respectively, compared to 37.6% for the three and six months ended September 30, 2006.

LIQUIDITY AND CAPITAL RESOURCES

For the six-month period ended September 30, 2007, cash provided by operations was $7,423,285 compared to $2,208,157 for the same period one year ago. The increase in cash provided by operating activities was due primarily to fluctuations in working capital balances, including the timing of inventory purchases and income tax payments. Historically, the Company’s cash requirements increase during the period from April through September as caustic soda inventory levels increase as the majority of barges are received during this period. Cash used in investing activities increased by $1,964,949 for the six months ended September 30, 2007 compared to the same period one year ago, primarily due to the acquisition of Trumark. Capital expenditures during the six months ended September 30, 2007 consisted primarily of facility improvement projects. Capital expenditures for the remainder of this fiscal year are expected to be relatively comparable with the three previous years and are expected to relate primarily to facilities improvement projects.

11


Table of Contents

Cash, cash equivalents and investments available-for-sale decreased by $2,620,106 from April 1, 2007 to $25,334,261 as of September 30, 2007 due primarily to dividends paid of $2,247,686 and the acquisition of Trumark during the six-month period ended September 30, 2007. Cash equivalents consist of money market accounts and certificates of deposit with an original maturity of three months or less. Investments available-for-sale consist of investment contracts with high-rated, stable insurance companies; marketable securities consisting of corporate and municipal bonds; U.S. Government agency securities and a mutual fund carried at fair value. The Company’s investment objectives in order of importance are the preservation of principal, maintenance of liquidity and rate of return. The fixed income portfolio consists primarily of investment grade securities to minimize credit risk, and they generally mature within 10 years. The Company invests in a mutual fund with characteristics similar to its fixed income portfolio to enhance its investment portfolio diversification. The Company monitors the maturities of its investments to ensure that funding is available for anticipated cash needs. At September 30, 2007, $1,185,259 of available-for-sale investments were classified as non-current assets as they were determined to be temporarily impaired with an aggregate carrying value exceeding market value by approximately $36,000 and have maturity dates of one year or longer. These investments were not determined to be other-than-temporarily impaired as the Company has the intent and ability to hold these investments for a period of time sufficient to allow a recovery of fair value. Expected future cash flows from operations, cash equivalents and investments included within current assets are expected to fund the Company’s short-term working capital needs.

At September 30, 2007, the Company had an investment portfolio of fixed income securities of $4,410,294, a mutual fund of $7,602,976, and $13,691,042 classified as cash and cash equivalents and variable rate securities. The fixed income securities, like all fixed income instruments, are subject to interest rate risk and will decline in value if market interest rates increase. However, while the value of the investment may fluctuate in any given period, the Company intends to hold its fixed income investments until maturity. Consequently, the Company would not expect to recognize an adverse impact on net income or cash flows or the amount ultimately realized on the investment. The value of the mutual fund, like all mutual funds, may increase or decrease due to market volatility. The mutual fund held by the Company as of September 30, 2007 is a short-term bond fund that invests primarily in investment grade securities.

Expected future cash flows from operations, coupled with the Company’s strong financial position, puts the Company in a position to fund both short and long-term working capital and capital investment needs with internally generated funds. Management does not, therefore, anticipate the need to engage in significant financing activities in either the short or long-term. If the need to obtain additional capital does arise, however, management is confident that the Company’s total debt to capital ratio at September 30, 2007 puts it in a position to obtain debt financing on favorable terms, although there can be no assurance of this.

Although management continually reviews opportunities to enhance the value of the Company through strategic acquisitions, other capital investments and strategic divestitures, no material commitments for such investments or divestitures currently exist.

CRITICAL ACCOUNTING POLICIES

The significant accounting policies followed by the Company are set forth in Note 1 to the Company’s financial statements in the Company’s Annual Report on Form 10-K for the fiscal year ended April 1, 2007. The accounting policies used in preparing the Company’s interim fiscal 2008 financial statements are the same as those described in the Company’s Annual Report.

Estimates - In preparing the financial statements, the Company follows accounting principles generally accepted in the United States. The preparation of these financial statements requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, sales and expenses, and related disclosure of contingent assets and liabilities. The Company re-evaluates its estimates on an on-going basis. The Company’s estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual results may differ from these estimates under different assumptions and conditions. The Company considers the following policies to involve the most judgment in the preparation of the Company’s financial statements.

Revenue Recognition – The Company recognizes revenue when title passes to our customers, which occurs primarily when product has been shipped, if there is evidence that the customer has agreed to purchase the products, performance has occurred, the price and terms of sale are fixed, and collection of the receivable is reasonably assured.

Investments – Statement of Financial Accounting Standard (SFAS) No. 115, “Accounting for Certain Investments in Debt and Equity Securities,” Securities and Exchange Commission (SEC) Staff Accounting Bulletin (SAB) 59, “Accounting for Noncurrent Marketable Equity Securities,” and FASB Staff Position (FSP) FAS No. 115-1 and FAS No. 124-1, “The Meaning of Other-Than-Temporary Impairment and Its Application to Certain Investments” provide guidance on determining when an investment is other-than-temporarily impaired. Investments are reviewed quarterly for indicators of other-than-temporary impairment. This determination requires significant judgment. In making this judgment, we evaluate, among other factors, the duration and extent to which the fair value of an investment is less than its cost; the general market conditions, including factors such as industry and sector performance, rating agency actions, and our intent and ability to hold the investment. Investments with an indicator are further evaluated to determine the likelihood of a significant adverse effect on the fair value and amount of the impairment as necessary. If market, industry and/or investee conditions deteriorate, we may incur future impairments.

12


Table of Contents

Allowance for Doubtful Accounts - Accounts receivable are reduced by an allowance for amounts that may become uncollectible in the future. Substantially all of the Company’s receivables are due from customers located in the United States. The estimated allowance for doubtful accounts is based upon the age of the outstanding receivables and the payment history and credit worthiness of each customer. Management evaluates the adequacy of the allowance for doubtful accounts on a quarterly basis. There can be no assurance that our estimates will match actual amounts ultimately written off.

Inventories – Inventories are valued at the lower of cost or market. On a quarterly basis, management assesses the inventory quantities on hand to estimated future usage and sales and, if necessary, writes down the value of inventory deemed obsolete or excess to market. Though management considers these reserves adequate and proper, changes in sales volumes due to unexpected economic or competitive conditions are among the factors that could materially affect the adequacy of this reserve.

LIFO Reserve – Inventories are primarily valued with cost being determined using the last-in, first-out (LIFO) method. We may incur significant fluctuations in our gross margins due primarily to changes in the cost of a single, large-volume component of inventory. The price of this inventory component may vary depending on the balance between supply and demand. Management reviews the LIFO reserve on a quarterly basis.

Impairment of Long-Lived Assets – We evaluate the carrying value of long-lived assets, including intangible assets subject to amortization and property, plant, and equipment, when events and changes in circumstances warrant such a review, such as prolonged industry downturn or significant reductions in projected future cash flows. The carrying value of long-lived assets is considered impaired when the projected future undiscounted cash flows from such assets are less than their carrying value. In that event, a loss is recognized equal to the amount by which the carrying value exceeds the fair value of the long-lived assets. Significant judgments and assumptions are required in the forecast of future operating results used in the preparation of the estimated future cash flows. We periodically review the appropriateness of the estimated useful lives of our long-lived assets. Changes in these estimates could have a material effect on the assessment of long-lived assets.

Self Insurance – The Company purchases insurance for employee medical benefits. Third party insurance is carried for what is believed to be the major portion of potential exposures that would exceed the Company’s self-insured retentions. The Company has established a liability for potential uninsured claims. The Company considers factors such as known outstanding claims, historical experience, and other relevant factors in setting the liability. These reserves are monitored and adjusted when warranted by changing circumstances. Though management considers these balances adequate, a substantial change in the number and/or severity of claims could result in materially different amounts for this item.

Income Taxes – In the preparation of the Company’s financial statements, management calculates income taxes. This includes estimating the current tax liability as well as assessing temporary differences resulting from different treatment of items for tax and book accounting purposes. These differences result in deferred tax assets and liabilities, which are recorded on the balance sheet. These assets and liabilities are analyzed regularly and management assesses the likelihood that deferred tax assets will be recovered from future taxable income. A valuation allowance is established to the extent that management believes that recovery is not likely. Reserves are also established for potential and ongoing audits of federal and state tax issues. The Company routinely monitors the potential impact of such situations and believes that it is properly reserved. Valuations related to amounts owed and tax rates could be impacted by changes to tax codes, changes in statutory tax rates, the Company’s future taxable income levels and the results of tax audits.

 

 

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

At September 30, 2007, the Company had an investment portfolio of fixed income securities of $4,410,294, a mutual fund of $7,602,976, and cash and cash equivalents of $13,691,042. The fixed income securities, like all fixed income instruments, are subject to interest rate risks and will decline in value if market interest rates increase. However, while the value of the investment may fluctuate in any given period, the Company intends to hold its fixed income investments until maturity. Consequently, the Company would not expect to recognize an adverse impact on net income or cash flows during the holding period. The value of the mutual fund, like all mutual funds, may increase or decrease due to market volatility. The Company adjusts the carrying value of its investments down if an impairment occurs that is other than temporary.

13


Table of Contents

The Company is subject to the risk inherent in the cyclical nature of commodity chemical prices. However, the Company does not currently purchase forward contracts or otherwise engage in hedging activities with respect to the purchase of commodity chemicals. We generally attempt to pass changes in material prices to our customers, however, there are no assurances that we will be able to pass on the increases in the future.

 

 

ITEM 4.

CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

We maintain a system of disclosure controls and procedures designed to provide reasonable assurance as to the reliability of our published financial statements and other disclosures included in this report. Our management evaluated, with the participation of our Chief Executive Officer and our Chief Financial Officer, the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the quarter ended September 30, 2007 pursuant to Rule 13a-15(b) of the Securities Exchange Act of 1934 (the “Exchange Act”). Based upon their evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that our disclosure controls and procedures were effective as of the end of the quarter ended September 30, 2007 to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act is recorded, processed, summarized, and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms, and to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosures.

Changes in Internal Control

During the quarter, there was no change in the Company’s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.




14


Table of Contents

PART II. OTHER INFORMATION

 

 

ITEM 1A.

RISK FACTORS

There have been no material changes to the Company’s risk factors from those disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended April 1, 2007.

 

 

ITEM 4.

SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

The annual meeting of the shareholders of the Company was held on August 7, 2007. Proxies for the annual meeting were solicited pursuant to Regulation 14A of the Exchange Act. There was no solicitation in opposition to the Board of Director nominees listed in the proxy statement and all of the nominees for director were elected with the following votes:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For

 

Withheld

 

Abstain

 

Broker
Non-votes

 

 

 

 

 

 

 

 

 

 

 

John R. Hawkins

 

 

8,646,696

 

 

29,268

 

 

0

 

 

0

 

Howard M. Hawkins

 

 

8,645,766

 

 

30,198

 

 

0

 

 

0

 

John S. McKeon

 

 

7,572,070

 

 

1,103,894

 

 

0

 

 

0

 

Duane M. Jergenson

 

 

8,656,346

 

 

19,618

 

 

0

 

 

0

 

G. Robert Gey

 

 

8,656,696

 

 

19,268

 

 

0

 

 

0

 

Daryl I. Skaar

 

 

8,649,567

 

 

26,397

 

 

0

 

 

0

 

Eapen Chacko

 

 

8,655,596

 

 

20,368

 

 

0

 

 

0

 

James A. Faulconbridge

 

 

8,655,246

 

 

20,718

 

 

0

 

 

0

 


 

 

ITEM 6.

EXHIBITS

Exhibit Index

 

 

 

 

 

Exhibit

 

Description

 

Method of Filing

3.1

 

Amended and Second Restated Articles of Incorporation as amended through February 27, 2001. (1)

 

Incorporated by Reference

 

 

 

 

 

3.2

 

Second Amended and Superseding By-Laws as amended through February 15, 1995. (2)

 

Incorporated by Reference

 

 

 

 

 

10.1

 

Summary of Non-Employee Director Compensation

 

Filed Electronically

 

 

 

 

 

31.1

 

Certification by Chief Executive Officer pursuant to Rule 13a-14(a) of the Exchange Act.

 

Filed Electronically

 

 

 

 

 

31.2

 

Certification by Chief Financial Officer pursuant to Rule 13a-14(a) of the Exchange Act.

 

Filed Electronically

 

 

 

 

 

32.1

 

Section 1350 Certification by Chief Executive Officer.

 

Filed Electronically

 

 

 

 

 

32.2

 

Section 1350 Certification by Chief Financial Officer.

 

Filed Electronically


 

 

 

 

(1)

Incorporated by reference to Exhibit 3.1 to the Company’s Annual Report on Form 10-K for the year ended September 30, 2001.

 

 

 

 

(2)

Incorporated by reference to Exhibit 3.2 to the Company’s Annual Report on Form 10-K for the year ended October 1, 1995.

15


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

 

HAWKINS, INC.

 

 

 

 

By:

/s/ Marvin E. Dee

 

 

 

 

 

 

 

 

Marvin E. Dee

 

 

 

 

 

Vice President, Chief Financial Officer, Secretary and Treasurer

 

 

(On behalf of the Registrant and as principal financial officer)

Dated: November 9, 2007

 

 









16


Table of Contents

Exhibit Index

 

 

 

 

 

 

 

 

 

 

Exhibit

 

Description

 

Method of Filing

3.1

 

Amended and Second Restated Articles of Incorporation as amended through February 27, 2001. (1)

 

Incorporated by Reference

 

 

 

 

 

3.2

 

Second Amended and Superseding By-Laws as amended through February 15, 1995. (2)

 

Incorporated by Reference

 

 

 

 

 

10.1

 

Summary of Non-Employee Director Compensation

 

Filed Electronically

 

 

 

 

 

31.1

 

Certification by Chief Executive Officer pursuant to Rule 13a-14(a) of the Exchange Act.

 

Filed Electronically

 

 

 

 

 

31.2

 

Certification by Chief Financial Officer pursuant to Rule 13a-14(a) of the Exchange Act.

 

Filed Electronically

 

 

 

 

 

32.1

 

Section 1350 Certification by Chief Executive Officer.

 

Filed Electronically

 

 

 

 

 

32.2

 

Section 1350 Certification by Chief Financial Officer.

 

Filed Electronically


 

 

(1)

Incorporated by reference to Exhibit 3.1 to the Company’s Annual Report on Form 10-K for the year ended September 30, 2001.

 

 

(2)

Incorporated by reference to Exhibit 3.2 to the Company’s Annual Report on Form 10-K for the year ended October 1, 1995.







17